Expanded use of sodium‐glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction.Published in:Pharmacotherapy, 2023, v. 43, n. 9, p. 950, doi. 10.1002/phar.2839By:Schoenborn, Erika Michelle;Skersick, Preston Trudell;Thrasher, Claire Maxine;Page, Robert L.Publication type:Article